| Dr Steve C Mitchell Sr, OD | |
|
624 S National Ave, Fort Scott, KS 66701-1317 | |
| (620) 223-6440 | |
| (620) 223-6988 |
| Full Name | Dr Steve C Mitchell Sr |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 47 Years |
| Location | 624 S National Ave, Fort Scott, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225034713 | NPI | - | NPPES |
| 188855 | Other | KS | COVENTRY HEALTHCARE |
| 5120 | Other | KS | BLUE CROSS BLUE SHIELD |
| 23665019 | Other | KS | BCBS OF KANSAS CITY |
| 100090050A | Medicaid | KS | |
| 410014059 | Other | KS | MEDICARE RAILROAD |
| 664300 | Other | KS | FIRST GUARD |
| 338790 | Other | KS | FAMILY HEALTH PARTNERS |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steve C Mitchell Sr, OD 624 S National Ave, Fort Scott, KS 66701-1317 Ph: (620) 223-6440 | Dr Steve C Mitchell Sr, OD 624 S National Ave, Fort Scott, KS 66701-1317 Ph: (620) 223-6440 |
News Archive
Cambridge Heart, Inc., today announced that the Company has completed the development phase of its Microvolt T-wave Alternans (MTWA) OEM Module, and has submitted a 510(k) application for regulatory approval with the U.S. Food and Drug Administration (FDA). The module is the centerpiece of the Company's new business model that involves partnering with leading stress test equipment manufacturers to broaden the distribution and use of MTWA technology.
Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL- (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.
› Verified 1 days ago
Dr. Randall Holloway, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4 S National Ave, Fort Scott, KS 66701 Phone: 620-223-0850 | |
Dr. Destiny Denise Foulk, OD Optometrist Medicare: Medicare Enrolled Practice Location: 624 S National Ave, Fort Scott, KS 66701 Phone: 620-223-6440 Fax: 620-223-6998 | |
Randall R Holloway Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4 S National Ave, Fort Scott, KS 66701 Phone: 620-223-0850 Fax: 620-223-2464 | |
Kannarr Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4 S National Ave, Fort Scott, KS 66701 Phone: 620-223-0850 Fax: 620-223-2464 | |
Eye Center Of Fort Scott Optometrist Medicare: Not Enrolled in Medicare Practice Location: 624 S National Ave, Fort Scott, KS 66701 Phone: 620-223-6440 Fax: 620-223-6988 | |
Eye Center Of Fort Scott Optometrist Medicare: Not Enrolled in Medicare Practice Location: 624 S National Ave, Fort Scott, KS 66701 Phone: 620-223-6440 Fax: 620-223-6988 |